One such interaction involves the myeloid cell marker CD11b on TAMs and CD90 on cancer stem cells, accompanied by EphA4 and epinephrine leading to the release of several other immunosuppressive cytokines that help maintain cancer stemness and survival[55]. The gene discussed is EPHA4; the disease is cancer.